ProQR Therapeutics N.V. Ordinary Shares (PRQR) Stock
NASDAQ · PRQR
1.86
Fundamentals
Market cap
$258.25M
Price / Earnings ratio
-4.1x
Price / Sales ratio
9.4x
Price / Book ratio
2.2x
Return on assets
-0.4%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About ProQR Therapeutics N.V. Ordinary Shares
No description available.
SectorHealthcare
IndustryBiotechnology
Employees186
CEOMr. Daniel Anton de Boer
IPO DateSep 18, 2014
HeadquartersLeiden, Netherlands
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Daniel Anton de Boer | Founder, CEO & Executive Director | 1983 |
| Dr. Gerard Platenburg Ph.D. | Co-Founder, Chief Scientific Officer & Executive Director | 1964 |
| Mr. Dennis Hom | Chief Financial Officer | 1975 |
| Ms. Sheila Sponselee | Chief People & Operations Officer | 1984 |
| Ms. Sarah Cue Kiely | Vice President of Investor Relations & Corporate Communications | — |
| Dr. Cristina Lopez Lopez M.D., Ph.D. | Chief Medical Officer | 1976 |
| Ms. Sandra van der Kolk | Junior Financial Controller | — |
Fundamentals
Valuation
Market cap$258.25M
Price-to-sales ratio9.41
Price-to-book value2.18
Price-earnings ratio-4.10
Return on Equity-86.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratio0.00
Earnings Per Share
Earnings Per Share$-0.44
Income Statement
Average volume747,489
EBITDA$-46.84M
1 year high (52w)$3.10
1 year low (52w)$1.33
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



